You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
何(柏)良:本港已具備實施入境檢疫「0+0」條件
阿思達克 10-12 11:24
香港大學感染及傳染病中心總監何(柏)良在電台節目表示,本港新冠疫苗接種率高,亦有新冠口服藥,認為已具備實施入境檢疫「0+0」方案的條件,相信可以做到行政長官李家超所指的「穩打穩紮」。他認為,目前要聚焦推動市民接種加強劑,並盡快安排受感染但未完成基本接種的長者服食口服藥。 他又提到,免針紙有法例基礎,醫生簽發時要守法及嚴格遵守政府指引。科興及復必泰疫苗均有藥物標籤,表明涉及的禁忌症,而同時涉及兩款疫苗藥物標籤的市民數量比例很低,相信本港人數不會有數萬人。他又建議當局考慮引入第三款疫苗,作為雙贏方案。 就病人本身病患因素方面,何(柏)良說,除非有關市民曾接種兩款疫苗,否則醫生難以表示有關人士對兩款疫苗皆有敏感情況。另外,各種長期病患,包括糖尿病、腎病、肝病、心臟病、中風和皮膚敏感等,都並非不宜接種的原因,強調醫生簽發「免針紙」要按證據,如隨便填寫病人不宜打針的原因,未必符合衛生署指引,會有後果。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account